Pioneered the introduction of the BCG vaccine to combat tuberculosis in Ireland.
On April 27, 1943, Dr. Dorothy Stopford Price led the introduction of the Bacillus Calmette–Guérin (BCG) vaccine in Ireland, a landmark achievement in the fight against tuberculosis. Tuberculosis was a significant public health issue in Ireland, and the introduction of the vaccine marked a turning point. At a time when infectious diseases ravaged the population, particularly the urban poor, this vaccine offered a new hope.
The adoption of BCG vaccination had a profound impact on public health across Ireland, dramatically reducing the incidence of tuberculosis. Her advocacy and efforts were met with resistance initially, but her persistence ultimately led to the successful implementation of widespread vaccination programs. Dr. Price faced numerous barriers, including skepticism from the conservative medical community and logistical challenges, but her determination and commitment to public health prevailed.
This achievement not only enhanced her reputation internationally but also established new public health precedents within Ireland, paving the way for future vaccines to be more readily accepted by the public. Her work fundamentally altered the course of tuberculosis treatment in the country.